BIOCURCUMAX™ - for High Bio-Activity
(A Patent pending product)

Product code BCM – 95 SG BCM 95 CG BCM – 95 DC
Application Softgel capsulation Hardgel capsulation Tabletting
Raw material to extract ratio 25:1 25 : 1 25 : 1
Colour and appearance Yellowish to orange red powder Yellowish orange free flowing powder Yellowish orange granules
Odour Characteristic Characteristic Characteristic-turmeric like
Curcuminoids COMPLEX with Volatile compounds NLT 95% NLT 95%  NLT 95% 
Bulk density (Gm/Ml)(Tapped) 0.5500 – 0.7000 0.6500 – 0.8000 0.5500 – 0.7000
Bulk density (Gm/Ml)(Untapped) 0.3000 – 0.4500 0.4500 – 0.6000 0.4500-0.6000
Residual solvent Ethyl acetate - below 30 ppm Ethyl acetate - below 30 ppm Ethyl acetate - below 30 ppm
Solubility Soluble in acetone Soluble in acetone Soluble in acetone
Total heavy metals Less than 10 ppm Less than 10 ppm Less than 10 ppm
Lead Less than 2 ppm Less than 2 ppm Less than 2 ppm
Total plate count (CFU/GM) 1000 maximum 1000 maximum 1000 maximum
Yeast and Mould (CFU/GM) 100 maximum 100 maximum 100 maximum
Salmonella Negative Negative Negative
E. Coli ( CFU/GM ) Negative Negative Negative
Packing 25 kgs HDPE drums with outer carton packing 25 kgs HDPE drums with outer carton packing 25 kgs HDPE drums with outer carton packing
Shelf life 24 months 24 months Keep in cool and inert atmosphere away from moisture 24 months Keep in cool and inert atmosphere away from moisture


U.S. Distributors:-
DolCas Biotech LLC
9 Lenel Road
Landing, NJ 07850
USA
Phone: 973-448-2805
Contact : Mr. K.G.Rao
www.dolcas-biotech.com
grao@dolcas-biotech.com
 
Biocurcumax™, the inventive product derived through an inventive process as part of process re-engineering. Biocurcumax™ is 100% Turmeric Extract .Biocurcumax™ offers a unique technique and concept to significantly enhance the bio-availability and thus the bio-activity retained for a longer period at an appreciably higher level as compared to conventional curcumin for enhanced efficacy, safety and usage convenience.

Despite the impressive array of beneficial bioactivities, the bioavailability of curcumin in animals and man remains low. In rodents, curcumin demonstrates poor systemic bioavailability after p.o. dosing which may be related to its inadequate absorption and fast metabolism. Curcumin bioavailability may also be poor in humans as seen from the results of a recent pilot study of a standardized turmeric extract in colorectal cancer patients. Indirect evidence suggests that curcumin is metabolized in the intestinal tract. Curcumin undergoes metabolic O-conjugation to curcumin glucuronide and curcumin sulfate and bioreduction to tetrahydrocurcumin, hexahydrocurcumin and hexahydrocurcuminol in rats and mice in vivo
 

 
© 2005 Arjuna Natural Extracts Ltd